alexa

GET THE APP

Dersleri yüzünden oldukça stresli bir ruh haline sikiş hikayeleri bürünüp özel matematik dersinden önce rahatlayabilmek için amatör pornolar kendisini yatak odasına kapatan genç adam telefonundan porno resimleri açtığı porno filmini keyifle seyir ederek yatağını mobil porno okşar ruh dinlendirici olduğunu iddia ettikleri özel sex resim bir masaj salonunda çalışan genç masör hem sağlık hem de huzur sikiş için gelip masaj yaptıracak olan kadını gördüğünde porn nutku tutulur tüm gün boyu seksi lezbiyenleri sikiş dikizleyerek onları en savunmasız anlarında fotoğraflayan azılı erkek lavaboya geçerek fotoğraflara bakıp koca yarağını keyifle okşamaya başlar
Staging Hepatic Fibrosis In HCV Patients | 25301
ISSN: 2161-069X

Journal of Gastrointestinal & Digestive System
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 1499

Journal of Gastrointestinal & Digestive System received 1499 citations as per Google Scholar report

Journal of Gastrointestinal & Digestive System peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Staging hepatic fibrosis in HCV patients

3rd International Conference on Gastroenterology & Urology

Theresa C Hemsworth-Peterson

Accepted Abstracts: J Gastroint Dig Syst

DOI: 10.4172/2161-069X.S1.023

Abstract
The advancement of antiviral therapy for hepatitis C, especially the encouraging results using triple therapy combining telaprevir with PEG-interferon and ribavirin, suggest a need for a reliable index of fibrotic stage. Fibrosis is one of the main predictors of the progression of chronic hepatitis C and its assessment by liver biopsy can determine therapy. However, biopsy is an invasive procedure with several limitations including poor reflection of extent of fibrosis in the whole liver. The fibrogenic stimulation index (FSI) measures the increase in target cell proliferation when stimulated by patient serum. The aim of this study was to investigate the use of FSI in the evaluation of liver fibrosis in patients with chronic hepatitis C using the hepatic stellate cell as the target. It was prospectively enrolled 60 patients with chronic hepatitis C undergoing routine liver biopsy prior to consideration of treatment at our center. METAVIR liver fibrosis stages were assessed on biopsy specimens by a pathologist and FSI and P-III-P was performed using patients? sera samples. Results indicate that FSI had a significant correlation with METAVIR fibrosis stage. As well, serum P-III-P correlated with METAVIR fibrosis score. There was no correlation between FSI and METAVIR activity grade of hepatic inflammation. In conclusion, non-invasive assessment of FSI appears as a reliable tool to detect significant fibrosis or cirrhosis in patients with chronic hepatitis C. The FSI would be a useful index to select patients for antifibrotic therapy and to assess improvement in fibrosis during and after antiviral therapy in HCV patients.
Biography
Theresa C Hemsworth-Peterson is currently a Full Professor of Medicine at Dalhousie University and a Biomedical Research Scientist at the QEII Health Sciences Centre in Halifax. She received her Doctoral degree from Dalhousie University and Postdoctoral studies at the National Institutes of Health. She returned to Dalhousie as the first Research Scholar of the Dalhousie Medical Research Foundation and later served as its Chair. Her research focusses on G.I., liver disease and drug development and she holds several US patents. She has over 100 publications in top journals including Hepatology, Molecular Pharmacology and the European Journal of Pharmacology.
Top